Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chinese Women Get Breast Cancer Earlier Than In West, Study Says

This article was originally published in PharmAsia News

Executive Summary

A Chinese study concluded Asian women have a lower rate of breast cancer than elsewhere, but they develop the disease at a much younger age

A Chinese study concluded Asian women have a lower rate of breast cancer than elsewhere, but they develop the disease at a much younger age.

The Cancer Foundation of China said a 10-year study showed most Chinese patients develop the disease in their 40s, about 10 years younger than the average for Western women. Of 4,200 women surveyed, nearly 40% were diagnosed with the disease in their 40s, a finding the lead researcher said suggested a need for more-targeted intervention in China. He suggested screening for breast cancer should begin at age 35. He added the mortality rate in China is rising at the same time it is lowering elsewhere. (Click here for more)

"Breast Cancer Is Hitting Chinese Women Earlier" - People's Daily (China) (3/28/11)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC077510

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel